This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback